Physician profile
Christopher Kuc
NPI 1073513412
$51,942.53
in general payments reported to CMS, 2019-2025
32 companies · $39K in 2025
The $39K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,635 · 2020: $67.46 · 2021: $931 · 2022: $1,330 · 2023: $2,078 · 2024: $5,990 · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $34K · Food and Beverage: $7,774 · Travel and Lodging: $2,870 · Consulting Fee: $2,210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $34,125.00 |
| Food and Beverage | $7,774.08 |
| Travel and Lodging | $2,869.65 |
| Consulting Fee | $2,210.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $39,930.04 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Alcon Vision LLC | $1,694.18 | 2019-2025 | Clareon, Tryptyr, Eysuvis |
| Tarsus Pharmaceuticals, INC. | $1,670.67 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $1,269.83 | 2019-2025 | Cequa |
| Carl Zeiss Meditec, INC. | $983.75 | 2023-2025 | Forum, Cirrus Hd-Oct, Iolmaster 700 |
| Novartis Pharmaceuticals Corporation | $596.47 | 2019-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $589.95 | 2019-2021 | |
| Oyster Point Pharma, INC. | $509.10 | 2022-2025 | Tyrvaya, Ryzumvi |
| Biotissue Holdings INC. | $476.01 | 2019-2025 | |
| Lkc Technologies, INC. | $443.18 | 2023-2025 | |
| Dompe US, INC. | $409.42 | 2022-2025 | Oxervate |
| Allergan, INC. | $387.32 | 2019-2022 | |
| Harrow Eye, LLC | $356.74 | 2024-2025 | Vevye |
| Carl Zeiss Meditec USA, INC. | $350.00 | 2024 | Clarus, Cirrus Hd-Oct, Atlas 500 |
| Rxsight INC | $326.06 | 2024-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $318.54 | 2019-2023 | Acuvue |
| Shire North American Group INC | $313.91 | 2019 | |
| Abbvie INC. | $296.30 | 2022-2024 | |
| Kala Pharmaceuticals, INC. | $231.16 | 2019-2021 | |
| Coopervision INC. | $209.81 | 2019-2025 | Myday Contact Lens, Paragon Crt |
| Quidel Corporation | $151.20 | 2022 | |
| Horizon Therapeutics Plc | $95.71 | 2021-2023 | Tepezza |
| Visioneering Technologies, INC. | $94.25 | 2019-2020 | |
| Thea Pharma INC. | $45.94 | 2022-2023 | Iyuzeh |
| Topcon Healthcare, INC. | $36.72 | 2022 | |
| Tearlab Corp | $34.37 | 2022-2024 | Scoutpro Osmolarity System |
| Abb Con-Cise Optical Group LLC | $29.98 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $25.15 | 2023 | Catalys System, Tecnis Iol |
| Sight Sciences, INC. | $22.03 | 2022 | |
| Notal Vision, INC. | $16.70 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $14.57 | 2019 | |
| Eyevance Pharmaceuticals LLC | $13.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Kuc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.